Skip to main content
HR 406 114th Congress House

Combination Drug Development Incentive Act of 2015

Official title: To amend section 505 of the Federal Food, Drug, and Cosmetic Act to provide incentives for the development of new combination drugs.

Introduced: January 20, 2015 See on congress.gov
Health Drug safety, medical device, and laboratory regulationPrescription drugsProduct development and innovation
Sign in to write a letter Sign in to watch
This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 23, 2015
Referred to the Subcommittee on Health.
Jan 20, 2015
Referred to the House Committee on Energy and Commerce.
Jan 20, 2015
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action January 23, 2015

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Combination Drug Development Incentive Act of 2015

This bill amends the Federal Food, Drug, and Cosmetic Act to provide a five-year marketing exclusivity period to a new drug approved by the Food and Drug Administration that is a novel combination of active ingredients. The application for the combination drug must contain reports of new clinical investigations that are essential to approval and were conducted or sponsored by the applicant. Currently, a new drug that includes an active ingredient that has already been approved is provided a three-year marketing exclusivity period.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 406: Combination Drug Development Incentive Act of 2015. 114th Congress. Open America. https://openamerica.io/bill/114-HR-406/
MLA
"H.R. 406: Combination Drug Development Incentive Act of 2015." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-406/.
Bluebook (legal)
H.R. 406, 114th Cong. (2026), https://openamerica.io/bill/114-HR-406/.
Markdown link
[H.R. 406: Combination Drug Development Incentive Act of 2015](https://openamerica.io/bill/114-HR-406/)
Report a problem